Bessemer Group’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $387K | Sell |
5,639
-102
| -2% | -$6.93K | ﹤0.01% | 1237 |
|
|
2026
Q1 | $430K | Buy |
5,741
+608
| +12% | +$49.8K | ﹤0.01% | 1173 |
|
|
2025
Q4 | $401K | Sell |
5,133
-57
| -1% | -$4.63K | ﹤0.01% | 1198 |
|
|
2025
Q3 | $441K | Buy |
5,190
+1
| +0% | +$80 | ﹤0.01% | 896 |
|
|
2025
Q2 | $406K | Buy |
5,189
+260
| +5% | +$19.2K | ﹤0.01% | 893 |
|
|
2025
Q1 | $357K | Buy |
4,929
+208
| +4% | +$17.5K | ﹤0.01% | 957 |
|
|
2024
Q4 | $418K | Buy |
4,721
+634
| +16% | +$56.5K | ﹤0.01% | 930 |
|
|
2024
Q3 | $346K | Sell |
4,087
-104
| -2% | -$9.23K | ﹤0.01% | 990 |
|
|
2024
Q2 | $388K | Sell |
4,191
-121
| -3% | -$12.2K | ﹤0.01% | 866 |
|
|
2024
Q1 | $487K | Sell |
4,312
-857
| -17% | -$85.6K | ﹤0.01% | 813 |
|
|
2023
Q4 | $482K | Sell |
5,169
-51,814
| -91% | -$4.56M | ﹤0.01% | 835 |
|
|
2023
Q3 | $5.23M | Buy |
56,983
+52,684
| +1,225% | +$5.66M | 0.01% | 351 |
|
|
2023
Q2 | $521K | Buy |
4,299
+4,254
| +9,453% | +$459K | ﹤0.01% | 802 |
|
|
2023
Q1 | $4K | Hold |
45
| – | – | ﹤0.01% | 1717 |
|
|
2022
Q4 | $4K | Sell |
45
-112
| -71% | -$9.4K | ﹤0.01% | 1684 |
|
|
2022
Q3 | $12K | Buy |
157
+112
| +249% | +$10.8K | ﹤0.01% | 1509 |
|
|
2022
Q2 | $5K | Hold |
45
| – | – | ﹤0.01% | 1541 |
|
|
2022
Q1 | $4K | Hold |
45
| – | – | ﹤0.01% | 1630 |
|
|
2021
Q4 | $4K | Hold |
45
| – | – | ﹤0.01% | 1686 |
|
|
2021
Q3 | $5K | Hold |
45
| – | – | ﹤0.01% | 1523 |
|
|
2021
Q2 | $5K | Hold |
45
| – | – | ﹤0.01% | 1434 |
|
|
2021
Q1 | $5K | Hold |
45
| – | – | ﹤0.01% | 1402 |
|
|
2020
Q4 | $5K | Hold |
45
| – | – | ﹤0.01% | 1388 |
|
|
2020
Q3 | $4K | Sell |
45
-12,500
| -100% | -$1.08M | ﹤0.01% | 1226 |
|
|
2020
Q2 | $1.02M | Hold |
12,545
| – | – | ﹤0.01% | 776 |
|
|
2020
Q1 | $866K | Sell |
12,545
-200
| -2% | -$21.1K | ﹤0.01% | 640 |
|
|
2019
Q4 | $1.46M | Sell |
12,745
-17,755
| -58% | -$2.21M | ﹤0.01% | 655 |
|
|
2019
Q3 | $3.98M | Buy |
30,500
+800
| +3% | +$104K | 0.01% | 349 |
|
|
2019
Q2 | $3.64M | Hold |
29,700
| – | – | 0.01% | 375 |
|
|
2019
Q1 | $3.12M | Buy |
29,700
+7,900
| +36% | +$849K | 0.01% | 357 |
|
|
2018
Q4 | $2.23M | Buy |
21,800
+12,400
| +132% | +$1.38M | 0.01% | 351 |
|
|
2018
Q3 | $1.11M | Buy |
9,400
+9,300
| +9,300% | +$1.05M | ﹤0.01% | 547 |
|
|
2018
Q2 | $10K | Buy |
+100
| New | +$9.28K | ﹤0.01% | 1499 |
|
|
2017
Q4 | – | Sell |
-12,700
| Closed | -$780K | – | 1828 |
|
|
2017
Q3 | $780K | Hold |
12,700
| – | – | ﹤0.01% | 718 |
|
|
2017
Q2 | $767K | Sell |
12,700
-700
| -5% | -$44.7K | ﹤0.01% | 742 |
|
|
2017
Q1 | $875K | Sell |
13,400
-4,476
| -25% | -$317K | ﹤0.01% | 754 |
|
|
2016
Q4 | $1.25M | Buy |
17,876
+176
| +1% | +$11.2K | 0.01% | 648 |
|
|
2016
Q3 | $1.11M | Buy |
+17,700
| New | +$1.09M | 0.01% | 583 |
|
|
2016
Q1 | – | Sell |
-135
| Closed | -$7K | – | 1660 |
|
|
2015
Q4 | $7K | Buy |
+135
| New | +$6.76K | ﹤0.01% | 1303 |
|
Other funds holding USPH
BG
CCM
SAM
Bessemer Group's USPH Position: Q2 2026 in Review
Bessemer Group reduced its US Physical Therapy (USPH) stake by 1.8% in Q2 2026, selling an estimated $6.93K and leaving 5,639 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #1237.
Bessemer Group first reported a position in USPH in Q4 2015 and has held it in 39 quarters since. The position peaked at $5.23M in Q3 2023. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.
- Bessemer Group held 5,639 shares of US Physical Therapy worth $387K as of Q2 2026.
- Bessemer Group sold 102 US Physical Therapy shares in Q2 2026, an estimated $6.93K.
- US Physical Therapy made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1237 holding.
- Bessemer Group first reported a position in US Physical Therapy in Q4 2015 and has held it in 39 quarters since.
- Bessemer Group's US Physical Therapy position peaked at $5.23M in Q3 2023.
- 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.
Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.